KFKeith Faulkner

Keith Faulkner

*This is an algorithmically generated author record based on publicly available information.

Keith Faulkner has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The revision of RP 91 on criteria for acceptability of radiological (including radiotherapy) andnuclear medicine installations

    by K. Faulkner, J. F. Malone, S. Christofides, S. Lillicrap, P. Horton

    In 1997 the European Commission published Radiation Protection 91: ‘Criteria for acceptability of radiological (including radiotherapy) and nuclear medicine installations’( 1). This document specified the minimum criteria for acceptability. It has been used to this effect in legislation, codes of practice and by individual professionals. In a single document, it defined a level of performance at which remedial action was required. The document specified a series of parameters which characterised equipment performance and acceptable levels of performance. In its time it proved to be a useful document which was applied in member states to various degrees. Since the publication of Report 91 in 1997( 1), a series of weaknesses emerged over time. Development of new radiological systems and technologies, as well as improvements in traditional technologies, has created circumstances where the acceptability criteria were in need of review. These weaknesses were recognised by the European Commission and a tender for its revision was issued. The criteria were developed by a team drawn from a broad range of backgrounds including hospitals, industry, government bodies, regulators and standardisation organisations. Representatives were mainly from Europe, but individuals from the American Association of Physicists in Medicine and International Atomic Energy Agency were included in the drafting process. This study describes the process employed in developing the revised document and the consultation process involved. One of the major difficulties the revision team encountered was related to an understanding of the actual meaning of the EC Directive( 2). The view taken by the revision team was that Article 8, paragraph 3 places responsibilities on both the holders of radiological equipment and competent authorities. The acceptability criteria have been produced consistent with the European Commission's Medical Exposures Directive( 2), which requires that patient exposures are optimised and justified.


  • Development of acceptability criteria in mammography

    by K. Faulkner, J. F. Malone, H. Bosmans

    Quality assurance protocols and standards of performance for X-ray mammography equipment are probably the most developed of any in the area of diagnostic radiology, due to the exacting demands on image quality required in population-based breast cancer screening programmes. Both qualitative and quantitative acceptability criteria have been published for X-ray mammography by considering the image quality needed clinically in screening programmes. Consequently, the task of developing a consensus for acceptability criteria appears to be relatively easy at first glance. However, there are two contentious issues that must be considered; the first is whether standards based on breast cancer screening can be transposed to equipment used for women referred for imaging with breast symptoms. The second relates to the use of image-quality assessment based upon the observation of details in test phantoms. In respect of the former, there was general agreement that only one set of acceptability criteria should apply to mammographic X-ray equipment. With regard to image-quality assessment, the weakness of the observer-based methods was recognised and a consensus position developed. This paper describes the development of a consensus on acceptability criteria and proposes both qualitative and quantitative criteria for use on all mammographic equipment. Some test approaches and criteria for image displays, in particular, were omitted from the document as concerns about their robustness emerged during the consultation phases of the revision. Clearly, further scientific work is needed in these areas.


  • A clinical audit programme for diagnostic radiology: the approach adopted by the International Atomic Energy Agency

    by K. Faulkner, H. Jarvinen, P. Butler, I. D. McLean, M. Pentecost, M. Rickard, B. Abdullah

    The International Atomic Energy Agency (IAEA) has a mandate to assist member states in areas of human health and particularly in the use of radiation for diagnosis and treatment. Clinical audit is seen as an essential tool to assist in assuring the quality of radiation medicine, particularly in the instance of multidisciplinary audit of diagnostic radiology. Consequently, an external clinical audit programme has been developed by the IAEA to examine the structure and processes existent at a clinical site, with the basic objectives of: (1) improvement in the quality of patient care; (2) promotion of the effective use of resources; (3) enhancement of the provision and organisation of clinical services; (4) further professional education and training. These objectives apply in four general areas of service delivery, namely quality management and infrastructure, patient procedures, technical procedures and education, training and research. In the IAEA approach, the audit process is initiated by a request from the centre seeking the audit. A three-member team, comprising a radiologist, medical physicist and radiographer, subsequently undertakes a 5-d audit visit to the clinical site to perform the audit and write the formal audit report. Preparation for the audit visit is crucial and involves the local clinical centre completing a form, which provides the audit team with information on the clinical centre. While all main aspects of clinical structure and process are examined, particular attention is paid to radiation-related activities as described in the relevant documents such as the IAEA Basic Safety Standards, the Code of Practice for Dosimetry in Diagnostic Radiology and related equipment and quality assurance documentation. It should be stressed, however, that the clinical audit does not have any regulatory function. The main purpose of the IAEA approach to clinical audit is one of promoting quality improvement and learning. This paper describes the background to the clinical audit programme and the IAEA clinical audit protocol.


  • Ethical concerns arising from screening procedures such as mammography and self-referral

    by K. Faulkner

    Shortly after the discovery of X-rays, their harmful effects became apparent. While the harmful effects of ionising radiation were recognised at an early stage, it took some time before a systematic approach to radiation protection evolved. This began with the development of simple rules to reduce the risk of stochastic effects (such as cancer induction) and the occurrence of deterministic injuries (e.g. cataract formation). These rules have evolved into the basic principles of radiation protection, one of which is the concept of justification, which in its simplest form may be taken as doing more benefit than harm. The concept of justification has particular ethical concerns when applied to population screening procedures. These problems are described in this paper with a particular emphasis on the cases of screening and self-referral procedures.


  • An estimate of the collective dose to the European population from cardiac X-ray procedures

    by K Faulkner, A Werduch

    There have been significant advances in interventional cardiology in recent years that have resulted in an increase in the frequency of both diagnostic and therapeutic X-ray-guided procedures. The number of coronary angiograms, percutaneous transluminal coronary angioplasties (PTCAs) and coronary stent procedures, as well as pacemaker insertions, has increased across Europe. X-ray-guided procedures are used in the treatment of complex cardiac problems and often involve the use of extended fluoroscopy times and the acquisition of a large number of images. There is increasing concern about the dose levels from these procedures, but their impact on the population dose is less well known. In this paper, the number of coronary procedures in various European countries is estimated and the population dose deduced. In addition, the total collective effective doses for cardiac procedures for various European countries have been estimated. In 2006, the estimated average number of coronary angiograms was 5045 per mi...


  • Evaluation of the population dose to the UK population from the National Health Service breast screening programme

    by K. Faulkner, M. G. Wallis, F. Neilson, C. J. Whitaker

    In the United Kingdom National Health Service Breast Screening Programme (NHSBSP), women aged between 50 and 70 y are invited for mammography every 3 y. Screening histories for each woman, over four screening rounds, were analysed. Data from five screening programmes were used to select 57 425 women into the study. Cases were selected on the basis of being between the ages of 50 and 53 at the start of the NHSBSP (i.e. between 1989 and 1992). Assessment of the outcome for each screening round for each woman involved assigning a simple outcome code. Each of the possible pathways through the four screening rounds was analysed. This comprises of 500 possible pathways. This data enabled the following information to be determined: (i) The number of times a woman attended the screening programme. (ii) The number of women referred for assessment at each screening round. This information may be used to deduce the population dose to this group of women averaged over four screening rounds. Patient doses have been monitored since the programme's inception and are typically 4.5 mGy for two-view screening. It is possible to determine the mean glandular dose received by this cohort of women over four screening rounds by multiplying the number of examinations by the mean glandular dose for a typical woman. Allowance has to be made for the number of projections taken at each screening round. Once a woman has been screened, she may be invited back for further assessment if an abnormality is found on her mammogram. A stereotactic attachment is used to determine where to place the biopsy device. Although the dose received during a normal screening mammogram is well known, the dose for a stereotactic procedure and other assessment procedures is less well known, partly because only a small part of the breast is directly irradiated during stereotaxis. However, the woman may have multiple exposures during this stage. A prospective survey of doses was completed to deduce the mean glandular dose at the first assessment stage and during stereotaxis. Numbers of films, including magnification films taken at first-stage assessment were established in the North East of England and Scotland by means of a postal survey. Average total mean glandular dose was deduced using previous survey data for the screening programme and a multiplying factor to allow for magnification film dose. On average 1.6 full field and 0.15 collimated contact films are taken for each woman (with 2.25 and 0.75 mGy film–1), 1.0 full field and 0.9 collimated magnification views. The mean magnification film dose to the assessed breast was 5.0 and 1.7 mGy for a collimated magnification film. A survey of 134 women at screening centres in the North East of England was performed to deduce the mean glandular dose from digital stereotaxis which is almost universally used in breast screening. A typical woman received a dose to the assessed breast of 4.5 mGy with a range of 1.3–17 mGy. This data may be used to deduce the total mean glandular dose over four screening rounds including the assessment stages. The estimated mean glandular dose to a typical woman invited to the screening programme is ∼16 mGy, when allowance for attendance rate and assessment rate over each screening round is made. The mean glandular dose to the population is ∼4700 Sv y−1.


  • Analysis of the frequency of interventional cardiology in various European countries

    by K. Faulkner, A. Werduch

    The contribution of interventional cardiology procedures to the population dose in Europe is poorly known. The estimation of the population dose from these procedures requires knowledge of both the typical dose received by patients and an estimate of the number of procedures undertaken annually. Data on the number of cardiology procedures in various European countries are available on the internet for a number of countries. However, this data set is incomplete or out of date. This paper describes the statistical analysis undertaken to estimate the number of interventional cardiology procedures in a number of European countries for 2007. Estimates of the number of procedures are given. On average, the number of cardiac catheterisations per million population is 5346, percutaneous transluminal coronary angioplasty is 1599 and 1214 stent procedures. In addition, there are an estimated 973 pacemaker insertions per million population.


  • The SENTINEL project

    by K. Faulkner, J. Malone, E. Vano, R. Padovani, H. P. Busch, J. (Hans) Zoetelief, H. Bosmans

    Health-care expenditure on radiological equipment in Europe is a growing fraction of the gross domestic product for all member states. This increase in expenditure has been driven by technical developments in equipment design, matched by the introduction of novel clinical practices, examinations and procedures. The radiation protection implications of these developments have to be assessed. The SENTINEL co-ordination action covered radiation protection, safety and related issues that arise from these technical and clinical developments. SENTINEL covered 90% of patient examinations in European Radiology, 60% of the collective dose from medical sources and ∼50% of the collective dose to European citizens from man-made sources. The SENTINEL co-ordination actions ‘main’ objective was to address the safety and efficacy issues which are common to all digital diagnostic imaging systems, including nuclear medicine. High-dose procedures and sensitive groups (such as children) were covered by the project. Specifically, the co-ordination action aimed: (1) to establish both physical and clinical image quality criteria and link the two, (2) to undertake a series of dosimetry studies to establish the reference levels for new procedures and (3) to develop good practice guidelines for radiation protection in digital imaging and produce training material.


  • The DIMOND project and its impact on radiation protection

    by K. Faulkner

    The DIMOND III project comprised work packages and subprojects to research digital imaging, interventional radiology and interventional cardiology, i.e. areas where there has been rapid technological change, not matched by radiation protection research. Whilst new practices have great potential benefit, there are risks to patients and staff if the technology is implemented inappropriately. DIMOND aimed to develop generic technology assessment and optimisation tools. Clinical quality criteria and technical parameters were included so that digital imaging procedures can be introduced appropriately. Frequency and dimensions of acceptance and constancy testing for digital imaging systems were studied, along with differences between objective measures of image quality and subjective indices. Patient dosimetry was performed to propose and to establish reference values. Clinical evaluation projects included cardiology, interventional radiology and digital mammography. As a result of the DIMOND project, quality criteria for several procedures were developed. Example results are presented in this paper.